We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

467 hedge funds and large institutions have $5.28B invested in Bioverativ Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $14.1M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
11.62%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$21.4M
Puts
$14.1M
Net Calls
+$7.29M
Net Calls Change
+$7.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$433M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$429M
3
VH
ValueAct Holdings
California
+$418M
4
Primecap Management
Primecap Management
California
+$381M
5
HM
HealthCor Management
New York
+$246M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PFO
401
Pathstone Family Office
New Jersey
$5K +$4.19K +85 New
VIA
402
Vantage Investment Advisors
Pennsylvania
$5K +$4.24K +86 New
MA
403
MCF Advisors
Kentucky
$5K +$4.53K +92 New
GBT
404
Grove Bank & Trust
Florida
$5K +$4.58K +93 New
GAM
405
Gemmer Asset Management
California
$5K +$4.63K +94 New
AssetMark Inc
406
AssetMark Inc
California
$5K +$4.68K +95 New
WA
407
WFG Advisors
Texas
$5K +$4.83K +98 New
CGT
408
Capital Guardian Trust
California
$5K +$4.88K +99 New
SIAP
409
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$5K +$4.93K +100 New
ED
410
Exane Derivatives
France
$4.74K +$4.29K +87 New
FPTW
411
Franklin, Parlapiano, Turner & Welch
Texas
$4K +$3.35K +68 New
IWM
412
IHT Wealth Management
Illinois
$4K +$3.65K +74 New
AIM
413
Arcadia Investment Management
Michigan
$4K +$3.69K +75 New
CPA
414
Clear Perspective Advisors
Illinois
$4K +$4.04K +82 New
DAM
415
Delta Asset Management
Tennessee
$3K +$2.46K +50 New
DSN
416
D. Scott Neal
Kentucky
$3K +$2.46K +50 New
BAM
417
Barrett Asset Management
New York
$3K +$2.51K +51 New
CPIG
418
Chicago Partners Investment Group
Illinois
$3K +$2.56K +52 New
CAG
419
Crestwood Advisors Group
Massachusetts
$3K +$2.66K +54 New
TFO
420
Tarbox Family Office
California
$3K +$2.66K +54 New
BFEC
421
Benjamin F. Edwards & Company
Missouri
$3K +$2.71K +55 New
HFM
422
Hartford Financial Management
Connecticut
$3K +$2.81K +57 New
GWS
423
Glassman Wealth Services
Virginia
$3K +$3K +61 New
GBBWRPM
424
Genovese Burford & Brothers Wealth & Retirement Plan Management
California
$2K +$1.13K +23 New
HR
425
Howe & Rusling
New York
$2K +$1.38K +28 New
15 16
17
18 19

BIVV Hedge Fund Activity: Q1 2017 in Review

467 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2017, worth a combined $5.28B.

Buyers outnumbered sellers: 467 funds opened new BIVV positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $433M.

  • 467 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $5.28B of Bioverativ Inc. Common Stock stock for Q1 2017.
  • 467 funds opened new Bioverativ Inc. Common Stock positions in Q1 2017 and 0 closed out, a net change of +467 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $433M added.

Based on aggregated 13F filings for Q1 2017.